Royalty Pharma plc

Royalty Pharma PLC

Biotechnology • Healthcare • New York, NY, United States • RPRX (NMS)

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

212 883 0200 110 East 59th Street, New York, NY 10022, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Financiere des Professionnels Fonds d investissement inc. Invests $933,000 in Royalty Pharma PLC $RPRX - MarketBeat
MarketBeat • Jan 4
Royalty Pharma plc (RPRX) Strikes $2B Partnership with Revolution Medicines - Yahoo Finance
Yahoo Finance • Aug 29
Royalty Pharma stock rises after acquiring full Evrysdi royalty - Investing.com
Investing.com • Dec 29
What's Going On With Royalty Pharma Stock Wednesday? - Royalty Pharma (NASDAQ:RPRX) - Benzinga
Benzinga • Dec 31
Royalty Pharma (RPRX): Reassessing Valuation After MYQORZO’s FDA Approval Unlocks New Royalty Cash Flows - simplywall.st
simplywall.st • Dec 23

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Royalty Pharma plc had layoffs?
No layoff events have been recorded for Royalty Pharma plc in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
What industry is Royalty Pharma plc in?
Royalty Pharma plc operates in the Biotechnology industry, within the Healthcare sector.
Is Royalty Pharma plc a publicly traded company?
Yes, Royalty Pharma plc is publicly traded under the ticker symbol RPRX on the NMS. The company has a market capitalization of approximately $22.87 billion.
Where is Royalty Pharma plc headquartered?
Royalty Pharma plc is headquartered in New York, NY, United States at 110 East 59th Street, New York, NY 10022, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.